内镜下置入金属支架治疗恶性胆道梗阻  

Therapy of Malignant Biliary Obstruction (MBO) by Endoscopic Placement of Metal Stent (EPMS)

作　　者：张爱民[1] 庞志锋[1] 丁建明[1] 王宛明[1] 柴玉萍[1] 

机构地区：[1]濮阳市人民医院消化科,457000

出　　处：《中国消化内镜》2007年第9期27-29,共3页Digestive Disease and Endoscopy

摘　　要：目的评估内镜下置放金属胆道支架对恶性胆道梗阻患者姑息治疗的疗效。方法本研究选取我院2002年7月至2006年10月间因恶性疾病所致的梗阻性黄疸不能或不愿外科手术的住院患者,共有42例接受了胆道金属支架置放术和随访观察。结果置放成功率与临床有效率分别是95.2%和95%,没有出现与手术相关的严重并发症。术后7天血清总胆红素平均下降73.7%,60天内的病死率为5%。支架置入后存活时间最短33天。有13例(22.5%)分别于术后3～37个月发生支架阻塞,经ERCP确定为支架阻塞,分别给予塑料支架置放术,其中5例先后予以2～4次塑料支架置放或更换术,最长存活者已4年余。结论对恶性胆道梗阻的支架治疗创伤性小,并发症发生率低,可持久胆汁引流、改善临床症状,提高患者的生存质量,延长生存期,是一种安全、有效的治疗方法。Objective: To evaluate the effect of palliative therapy of MBO by EPMS. Method: Without surgical opportunity,42 cases of obstructive jaundice caused by malignant disease were treated by EPMS and closely followed up between July 2002 and October 2006. Results: The success and effective rate were 95.2% and 95% respectively. No severe operation-related complication was present. The average reduction ratio of total bilirubin within 7 days was 73.7% posttherapeutically. The mortality rate within 60 days was 5%. ...

关 键 词：支架 恶性胆道梗阻 姑息治疗 

分 类 号：R735[医药卫生—肿瘤]